Technical Analysis for FHTX - Foghorn Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 7.86 | 0.77% | 0.06 |
FHTX closed up 0.77 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 0.77% | |
| Inside Day | Range Contraction | 0.77% | |
| MACD Bearish Signal Line Cross | Bearish | 1.95% | |
| Inside Day | Range Contraction | 1.95% | |
| Down 3 Days in a Row | Weakness | 1.95% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| Up 2% | about 20 hours ago |
| Rose Above Previous Day's High | about 21 hours ago |
| Up 1% | about 21 hours ago |
| Gap Down Closed | about 21 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.25 |
| 52 Week Low | 2.7 |
| Average Volume | 169,158 |
| 200-Day Moving Average | 6.84 |
| 50-Day Moving Average | 8.43 |
| 20-Day Moving Average | 8.38 |
| 10-Day Moving Average | 8.56 |
| Average True Range | 0.66 |
| RSI (14) | 43.82 |
| ADX | 20.69 |
| +DI | 16.26 |
| -DI | 21.39 |
| Chandelier Exit (Long, 3 ATRs) | 7.73 |
| Chandelier Exit (Short, 3 ATRs) | 9.11 |
| Upper Bollinger Bands | 9.56 |
| Lower Bollinger Band | 7.20 |
| Percent B (%b) | 0.28 |
| BandWidth | 28.18 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.12 |
| MACD Histogram | -0.119 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.54 | ||||
| Resistance 3 (R3) | 8.52 | 8.29 | 8.42 | ||
| Resistance 2 (R2) | 8.29 | 8.11 | 8.29 | 8.38 | |
| Resistance 1 (R1) | 8.07 | 8.01 | 8.18 | 8.09 | 8.35 |
| Pivot Point | 7.84 | 7.84 | 7.89 | 7.84 | 7.84 |
| Support 1 (S1) | 7.62 | 7.66 | 7.73 | 7.64 | 7.37 |
| Support 2 (S2) | 7.39 | 7.56 | 7.39 | 7.34 | |
| Support 3 (S3) | 7.17 | 7.39 | 7.30 | ||
| Support 4 (S4) | 7.19 |
